Home page

Our Mission

We are dedicated to developing better bioengineered tools to address unmet biomedical needs and biological questions. Through working at the interface of material sciences, biomedical engineering, biology and medicine, our interdisciplinary and collaborative team aims to develop next generation stem cell-based therapeutics and miniaturized diagnostics (Research). We are also fully committed to the professional development of the personnel in the laboratory and do everything we can to ensure successful career paths (Education).  If you are interested in joining the team, collaborating, donating, or are interested in what our research expertise can do for you, please contact Dr. Weian Zhao (weianzhao.uci@gmail.com).


Multiple positions available for highly motivated Postdocs, Graduate Students, Undergraduate students and Administrative Staffs who want to join an interdisciplinary and collaborative team to address unmet challenges in medicine. The applicants who have a background/interest in immunology, stem cell and cancer biology, in vitro selection and evolution, bioengineering and technology translation, and clinical oncology are particularly encouraged to apply.

April 13, 2015: Zhao lab picture selected for Third Annual Stem Cells Offer Hope Event flyer.

April 9, 2015: Zhao lab receives a R01 grant from National Institute of Allergy and Infectious Diseases (NIAID) on Antimicrobial Resistance Diagnostics Projects (NIH News).

March 31, 2015: Congratulations to Claire Chen and Neto Sosa in receiving the prestigious NSF graduate student fellowships.

February 4, 2015: Zhao lab receives a grant from Lymedisease.org to develop a better test for Lyme diseases.

January 28, 2015: IC 3D technology was highlighted in Lab on a Chip: Research highlights: microfluidic analysis of antimicrobial susceptibility.

January 9, 2015: Congratulations to undergraduate researchers, Louai, Eilbret, Abraham and Thi, in winning UROP Research Grant for 2015.

December 10, 2014: Zhao lab receives a grant from the UCI Chao Family Comprehensive Cancer Center to perform a clinical trial to evaluate our new CTC test in monitoring colon cancer.

November 13, 2014: Zhao lab Launches Velox Biosystems, startup aiming to transform rapid and sensitive diagnostics.

November 13, 2014: Congratulations to our Nature Communications paper. “Rapid detection of single bacteria in unprocessed blood using Integrated Comprehensive Droplet Digital Detection.Nature Communications, 2014, 5, 5427. Selected as Featured paper, Featured at UCI news.  

More news…

crystal cove-150by150

Comments are closed.